ARTV
Price
$3.85
Change
-$0.29 (-7.00%)
Updated
Feb 4, 02:21 PM (EDT)
Capitalization
101.62M
54 days until earnings call
Intraday BUY SELL Signals
RADX
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
37.83M
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARTV vs RADX

Header iconARTV vs RADX Comparison
Open Charts ARTV vs RADXBanner chart's image
Artiva Biotherapeutics
Price$3.85
Change-$0.29 (-7.00%)
Volume$2.35K
Capitalization101.62M
Radiopharm Theranostics
PriceLoading...
Change-$0.00 (-0.00%)
Volume$112.75K
Capitalization37.83M
ARTV vs RADX Comparison Chart in %
ARTV
Daily Signal:
Gain/Loss:
RADX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARTV vs. RADX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTV is a Hold and RADX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (ARTV: $4.14 vs. RADX: $4.87)
Brand notoriety: ARTV and RADX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTV: 13% vs. RADX: 11%
Market capitalization -- ARTV: $101.62M vs. RADX: $37.83M
ARTV [@Biotechnology] is valued at $101.62M. RADX’s [@Biotechnology] market capitalization is $37.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTV’s FA Score shows that 1 FA rating(s) are green whileRADX’s FA Score has 1 green FA rating(s).

  • ARTV’s FA Score: 1 green, 4 red.
  • RADX’s FA Score: 1 green, 4 red.
According to our system of comparison, ARTV is a better buy in the long-term than RADX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTV’s TA Score shows that 3 TA indicator(s) are bullish while RADX’s TA Score has 2 bullish TA indicator(s).

  • ARTV’s TA Score: 3 bullish, 4 bearish.
  • RADX’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ARTV is a better buy in the short-term than RADX.

Price Growth

ARTV (@Biotechnology) experienced а -14.64% price change this week, while RADX (@Biotechnology) price change was -1.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

ARTV is expected to report earnings on Mar 30, 2026.

RADX is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARTV($102M) has a higher market cap than RADX($37.8M). ARTV YTD gains are higher at: -3.497 vs. RADX (-6.705). RADX has higher annual earnings (EBITDA): -42.33M vs. ARTV (-83.6M). ARTV has more cash in the bank: 123M vs. RADX (36.4M). RADX has higher revenues than ARTV: RADX (1.68M) vs ARTV (0).
ARTVRADXARTV / RADX
Capitalization102M37.8M270%
EBITDA-83.6M-42.33M198%
Gain YTD-3.497-6.70552%
P/E RatioN/AN/A-
Revenue01.68M-
Total Cash123M36.4M338%
Total Debt11.7MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ARTVRADX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 14 days ago
86%
Bullish Trend 3 days ago
90%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARTV
Daily Signal:
Gain/Loss:
RADX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TKR96.141.15
+1.21%
Timken Company (The)
KMTS25.050.05
+0.18%
Kestra Medical Technologies, Ltd.
INLX8.21N/A
N/A
Intellinetics
PM177.00-2.94
-1.63%
Philip Morris International
XPOF8.58-0.42
-4.67%
Xponential Fitness

ARTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTV has been loosely correlated with KZR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTV jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTV
1D Price
Change %
ARTV100%
-0.96%
KZR - ARTV
42%
Loosely correlated
-0.33%
IRON - ARTV
41%
Loosely correlated
-1.17%
RANI - ARTV
40%
Loosely correlated
+2.50%
RADX - ARTV
35%
Loosely correlated
-5.44%
CELC - ARTV
34%
Loosely correlated
-0.31%
More

RADX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RADX has been loosely correlated with ARTV. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RADX jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RADX
1D Price
Change %
RADX100%
-5.44%
ARTV - RADX
35%
Loosely correlated
-0.96%
CVKD - RADX
27%
Poorly correlated
-7.04%
CRVO - RADX
25%
Poorly correlated
-0.82%
CSBR - RADX
25%
Poorly correlated
N/A
AKTX - RADX
22%
Poorly correlated
-1.60%
More